Pancreatic exocrine function and cyclic nucleotides in the diabetic rat

Area of Science:

• Biochemistry
• Endocrinology
• Physiology

Background:

• Diabetes mellitus is a metabolic disorder with known effects on various organs.
• Pancreatic exocrine function can be altered in diabetic states, impacting digestive enzyme production.

Purpose of the Study:

• To investigate the effects of streptozotocin-induced diabetes on pancreatic enzyme and cyclic nucleotide levels in rats.
• To determine the role of insulin treatment in reversing these diabetic-induced changes.
• To explore the involvement of cyclic nucleotides in pancreatic exocrine deficiency.

Main Methods:

• Induction of diabetes mellitus in rats using streptozotocin.
• Measurement of serum and pancreatic amylase, pancreatic trypsinogen, and pancreatic lipase levels.
• Quantification of plasma, urine, and pancreatic cyclic nucleotide (cAMP and cGMP) levels.
• Assessment of the effects of short-term insulin treatment on these parameters.

Main Results:

• Streptozotocin-induced diabetes caused significant decreases in pancreatic amylase and trypsinogen, and an increase in pancreatic lipase.
• Plasma cyclic nucleotide levels increased, while urine levels decreased, with no change in pancreatic levels.
• Insulin treatment normalized pancreatic amylase and trypsinogen but not lipase or serum amylase.
• Insulin partially reduced plasma cAMP levels, with no other significant effects on cyclic nucleotides.

Conclusions:

• Experimental diabetes profoundly affects pancreatic exocrine secretion of amylase and trypsinogen.
• The observed pancreatic exocrine deficiency in diabetes is reversible with insulin therapy.
• Cyclic nucleotides do not appear to directly mediate pancreatic exocrine deficiency in diabetes or its reversal by insulin.